Global Outlook February 2009.pdf - Grosvenor
Global Outlook February 2009.pdf - Grosvenor
Global Outlook February 2009.pdf - Grosvenor
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Global</strong> <strong>Outlook</strong> <strong>February</strong> 2009<br />
Chart 3: Germany is the largest market<br />
$ bn<br />
140<br />
120<br />
100<br />
80<br />
60<br />
40<br />
20<br />
0<br />
Spain UK Italy France Germany<br />
Source: WHO, <strong>Grosvenor</strong> Research, 2009<br />
Compared with standard commercial property,<br />
healthcare property vacancy and rental rates are less<br />
likely to exhibit the peaks and troughs of the property<br />
cycle. Healthcare property can offer attractive<br />
income returns. Although our analysis is limited by<br />
data availability, anecdotal evidence suggests that<br />
yields are relatively high, when compared to the main<br />
commercial sectors. This is hardly surprising, given<br />
the higher risk implied by this type of investment.<br />
Prime yields should range are expected to be<br />
between 7.0% and 9.0% for this kind of product.<br />
Moreover, the healthcare market in Continental<br />
Europe is characterised by long leases and offers<br />
indexation, albeit maybe not at full rate.<br />
As mentioned, investing in healthcare property is not, however, exempt from risks. The sector is still<br />
quite illiquid and lack of transparency maybe an issue as legislation and regulation are rather different<br />
across European countries. A specific risk of this sector is mismanagement risk, as it carries a severe<br />
reputational risk. On the other hand, re-letting risk may be mitigated as a result of government concern<br />
about continuity of services. These types of properties are also generally located in good central or<br />
countryside locations, making it easier to change the use of the building.<br />
This document is for general informative purposes only. The information has been compiled from sources believed to be reliable however its accuracy and<br />
completeness are not guaranteed. The opinions expressed are those of the Research Department of <strong>Grosvenor</strong> Group Limited ("<strong>Grosvenor</strong>") at this date<br />
and are subject to change without notice. Reliance should not be placed on the information, forecasts and opinions set out herein for any investment<br />
purposes and <strong>Grosvenor</strong> will not accept any liability arising from such use. This document is intended for professional and non-private investors only. No<br />
part of this publication may be reproduced in any form without the prior written permission of <strong>Grosvenor</strong>.